NexusPharma Information

Cancer is the second leading cause of death in the United States, and there is a continuing need to provide new, safer cancer drugs to patients. We at NexusPharma, a Genesis Drug Discovery and Development (GD3) Member Company, actively pursue this unmet need to provide effective discovery tools to select novel therapeutics with fewer side effects for cancer patients. Together with Fox Chase Cancer Center, a company co-founder, we are dedicated to developing patient-derived tumor disease models to advance the discovery of effective drugs.

Website	http://www.nexuspharm.com
Revenue	$11.3 million
Employees	4 (0 on RocketReach)
Address	1000 Waterview Dr, Hamilton, New Jersey 08691, US
Phone	+1 410-485-6327
Technologies	JavaScript , HTML , Google Analytics +16 more (view full list)
Industry	Biotechnology, Biotechnology Research, Business Services General, Business Services, Science and Engineering, Drug Discovery, Health Care, Pharmaceutical
Keywords	Cancer Drugs, Pharmaceutical Research, Drug Discovery, Drug Development, Cancer Treatment, Oncology, Clinical Trials, Biotechnology, New Drugs, Innovative Therapies, Clinical Research, Fda Approval, Medicinal Chemistry, Pharmaceutical Manufacturing, Pharma, Drug Regulation, Healthcare, Pharmaceutical Sales, Pharmaceutical Marketing
Competitors	Teva Pharmaceuticals, Mylan Belgium, Sandoz, Amgen, Roche, Bristol Myers Squibb, GSK, Pfizer, AbbVie, AstraZeneca +49 more (view full list)
SIC	SIC Code 87 Companies, SIC Code 873 Companies
NAICS	NAICS Code 541 Companies, NAICS Code 54171 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies, NAICS Code 541714 Companies